Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
BMC Genomics ; 25(1): 628, 2024 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-38914980

RESUMEN

BACKGROUND: Peritoneal carcinomatosis was the main reason leading to gastric cancer (GC)-related death. We aimed to explore the roles of dysregulated microRNAs (miRNAs) and related immune regulation activities in GC-associated malignant ascites. METHODS: GSE126399 were downloaded from GEO database. Differentially expressed miRNAs in GC ascites samples was firstly screened, and critical miRNAs were further investigated by LASSO (least absolute shrinkage and selection operator) logistic regression and random forest (RF) algorithm. Receiver operating characteristic of critical miRNAs was also constructed. Moreover, functional analysis, immune cell infiltration associated with differentially expressed mRNAs were further analyzed. After selecting key modules by weighted gene co-expression network analysis, mRNAs related with survival performance and transcription factor (TF)-miRNA-mRNA network were constructed. RESULTS: Hsa-miR-181b-5p was confirmed as critical differentially expressed miRNAs in GC ascites. Then, the tumor samples were divided into high- and low- expression groups divided by mean expression levels of hsa-miR-181b-5p, and subjects with high hsa-miR-181b-5p levels had better survival outcomes. In total, 197 differentially expressed mRNAs associated with hsa-miR-181b-5p levels were obtained, and these mRNAs were mainly enriched in muscle activity and vascular smooth muscle contraction. Hsa-miR-181b-5 was positively related with activated CD4 T cells and negatively related with eosinophil. 17 mRNAs were selected as mRNAs significantly related with prognosis of GC, such as PDK4 and RAMP1. Finally, 75 TF-miRNA-mRNA relationships were obtained, including 15 TFs, hsa-miR-181b-5p, and five mRNAs. CONCLUSION: Our data suggest that the differentially expressed hsa-miR-181b-5p in ascites samples of GC patients may be a valuable prognostic marker and a potential target for therapeutic intervention, which should be validated in the near future.


Asunto(s)
Ascitis , Biomarcadores de Tumor , MicroARNs , Neoplasias Gástricas , Humanos , MicroARNs/genética , MicroARNs/metabolismo , Neoplasias Gástricas/genética , Neoplasias Gástricas/patología , Ascitis/genética , Ascitis/metabolismo , Ascitis/patología , Pronóstico , Biomarcadores de Tumor/genética , Perfilación de la Expresión Génica , Redes Reguladoras de Genes , Regulación Neoplásica de la Expresión Génica , ARN Mensajero/genética , ARN Mensajero/metabolismo
2.
Medicina (Kaunas) ; 60(2)2024 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-38399576

RESUMEN

Background and Objectives: Ascites, often associated with liver cirrhosis, poses diagnostic challenges, particularly in detecting bacterial infections. Traditional methods have limitations, prompting the exploration of advanced techniques such as 16S rDNA next-generation sequencing (NGS) for improved diagnostics in such low-biomass fluids. The aim of this study was to investigate whether the NGS method enhances detection sensitivity compared to a conventional ascites culture. Additionally, we aimed to explore the presence of a microbiome in the abdominal cavity and determine whether it has a sterile condition. Materials and Methods: Ten patients with clinically suspected spontaneous bacterial peritonitis (SBP) were included in this study. A traditional ascites culture was performed, and all ascites samples were subjected to 16S ribosomal RNA gene amplification and sequencing. 16S rRNA gene sequencing results were interpreted by comparing them to positive and negative controls for each sample. Results: Differential centrifugation was applied to all ascites samples, resulting in very small or no bacterial pellets being harvested. The examination of the 16S amplicon sequencing libraries indicated that the target amplicon products were either minimally visible or exhibited lower intensity than their corresponding negative controls. Contaminants present in the reagents were also identified in the ascites samples. Sequence analysis of the 16S rRNA gene of all samples showed microbial compositions that were akin to those found in the negative controls, without any bacteria isolated that were unique to the samples. Conclusions: The peritoneal cavity and ascites exhibit low bacterial biomass even in the presence of SBP, resulting in a very low positivity rate in 16S rRNA gene sequencing. Hence, the 16S RNA sequencing method does little to enhance the rate of positive samples compared to traditional culture methods, including in SBP cases.


Asunto(s)
Ascitis , Peritonitis , Humanos , ARN Ribosómico 16S/genética , Ascitis/genética , Peritonitis/diagnóstico , Peritonitis/microbiología , Bacterias/genética , Secuenciación de Nucleótidos de Alto Rendimiento/métodos
3.
Oncogene ; 43(10): 714-728, 2024 03.
Artículo en Inglés | MEDLINE | ID: mdl-38225339

RESUMEN

Cisplatin resistance is a major cause of therapeutic failure in patients with high-grade serous ovarian cancer (HGSOC). Long noncoding RNAs (lncRNAs) have emerged as key regulators of human cancers; however, their modes of action in HGSOC remain largely unknown. Here, we provide evidence to demonstrate that lncRNA Platinum sensitivity-related LncRNA from Ascites-Derived Exosomes (PLADE) transmitted by ascites exosomes enhance platinum sensitivity in HGSOC. PLADE exhibited significantly decreased expression in ascites exosomes and tumor tissues, as well as in the corresponding metastatic tumors from patients with HGSOC cisplatin-resistance. Moreover, HGSOC patients with higher PLADE expression levels exhibited longer progression-free survival. Gain- and loss-of-function studies have revealed that PLADE promotes cisplatin sensitivity by suppressing cell proliferation, migration and invasion, and enhancing apoptosis in vitro and in vivo. Furthermore, the functions of PLADE in increasing cisplatin sensitivity were proven to be transferred by exosomes to the cultured recipient cells and to the adjacent tumor tissues in mouse models. Mechanistically, PLADE binds to and downregulates heterogeneous nuclear ribonucleoprotein D (HNRNPD) by VHL-mediated ubiquitination, thus inducing an increased amount of RNA: DNA hybrids (R-loop) and DNA damage, consequently promoting cisplatin sensitivity in HGSOC. Collectively, these results shed light on the understanding of the vital roles of long noncoding RNAs in cancers.


Asunto(s)
Neoplasias Ováricas , ARN Largo no Codificante , Animales , Ratones , Femenino , Humanos , ARN Largo no Codificante/genética , Cisplatino/farmacología , Cisplatino/uso terapéutico , Ascitis/genética , Estructuras R-Loop , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Ováricas/genética
4.
Poult Sci ; 103(5): 103388, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38428352

RESUMEN

Pulmonary artery remodeling is a characteristic feature of broiler ascites syndrome (BAS). Pulmonary artery endothelial cells (PAECs) regulated by HIF-1α play a critical role in pulmonary artery remodeling, but the underlying mechanisms of HIF-1α in BAS remain unclear. In this experiment, primary PAECs were cultured in vitro and were identified by coagulation factor VIII. After hypoxia and RNA interference, the mRNA and protein expression levels of HIF-1α and VEGF were determined by qPCR and Western blotting. The transcriptome profiles of PAECs were obtained by RNA sequencing. Our results showed that the positive rate of PAECs was more than 90%, hypoxia-induced promoted the proliferation and apoptosis of PAECs, and RNA interference significantly downregulated the expression of HIF-1α, inhibited the proliferation of PAECs, and promoted the apoptosis of PAECs. In addition, transcriptome sequencing analysis indicated that HIF-1α may regulate broiler ascites syndrome by mediating COL4A, vitronectin, vWF, ITGα8, and MKP-5 in the ECM, CAMs and MAPK pathways in PAECs. These studies lay the foundation for further exploration of the mechanisms of pulmonary artery remodeling, and HIF-1α may be a potentially effective gene for the prevention and treatment of BAS.


Asunto(s)
Pollos , Células Endoteliales , Subunidad alfa del Factor 1 Inducible por Hipoxia , Arteria Pulmonar , Interferencia de ARN , Animales , Arteria Pulmonar/metabolismo , Arteria Pulmonar/citología , Subunidad alfa del Factor 1 Inducible por Hipoxia/genética , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Células Endoteliales/fisiología , Células Endoteliales/metabolismo , Proliferación Celular , Proteínas Aviares/genética , Proteínas Aviares/metabolismo , Enfermedades de las Aves de Corral/genética , Ascitis/veterinaria , Ascitis/genética , Apoptosis , Células Cultivadas
5.
Oncogene ; 43(24): 1877-1882, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38654110

RESUMEN

Detection of peritoneal dissemination (PD) in gastric cancer (GC) patients remains challenging. The feasibility of tumor-guided cell-free DNA (cfDNA) detection in prospectively collected peritoneal fluid (ascites and peritoneal lavage) was investigated and compared to conventional cytology in 28 patients. Besides conventional cytology, next generation sequencing was performed on primary tumor DNA and cell-free DNA from peritoneal fluid. Patients were retrospectively grouped into: a positive group (with PD) and a negative group (without PD). Detectable mutations were found in the primary tumor of 68% (n = 19). Sensitivity of PD detection by tumor-guided cfDNA analysis was 91%, compared to 64% by conventional cytology. Within the positive group (n = 11), tumor-guided cfDNA was detected in all patients with ascites samples (4/4, 100%) and in 86% (6/7) of the lavage samples, opposed to 4/4 (100%) patients with ascites and 43% (3/7) with lavage by conventional cytology. Within the negative group (n = 8), conventional cytology was negative for all samples. In two patients, tumor-guided cfDNA was detected in peritoneal lavage fluid. Interestingly, these 2 patients developed PD within 6 months, suggesting a prognostic value of tumor-guided cfDNA detection. This study showed that tumor-guided cfDNA detection in peritoneal fluids of GC patients is feasible and superior to conventional cytology in detecting PD.


Asunto(s)
Líquido Ascítico , Ácidos Nucleicos Libres de Células , Neoplasias Peritoneales , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/genética , Neoplasias Gástricas/patología , Neoplasias Gástricas/diagnóstico , Neoplasias Peritoneales/secundario , Neoplasias Peritoneales/genética , Neoplasias Peritoneales/diagnóstico , Femenino , Líquido Ascítico/patología , Líquido Ascítico/metabolismo , Masculino , Persona de Mediana Edad , Anciano , Ácidos Nucleicos Libres de Células/genética , Estudios Retrospectivos , ADN Tumoral Circulante/genética , Adulto , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Biomarcadores de Tumor/genética , Ascitis/genética , Ascitis/patología , Ascitis/diagnóstico , Mutación , Anciano de 80 o más Años , Lavado Peritoneal , ADN de Neoplasias/genética , ADN de Neoplasias/análisis
6.
Vet Med Sci ; 10(5): e1542, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39049705

RESUMEN

BACKGROUND: Our hypothesis centred on the potential to mitigate ascites outbreaks in birds exposed to cold stress by inhibiting pulmonary artery contraction through dietary intervention. OBJECTIVE: This study aimed to evaluate the effect of natural and synthetic medications on growth performance, ascites-related parameters and the expression of ascites-related genes in the lung tissue of broiler chickens under low ambient temperature. METHODS: We randomly assigned 450 one-day-old male Ross 308 chicks to six dietary treatments across five replicate pens, each containing 15 chicks. The treatments included a basal diet (control), and the basal diet was supplemented with hydroalcoholic extracts of sumac (HES, 200 mg/kg), Syrian mesquite (HEM, 200 mg/kg), l-arginine (40% above requirement), captopril (15 mg/kg) and vitamin E (100 mg/kg). RESULTS: Diets containing HEM, l-arginine and vitamin E resulted in increased average daily gain on days 8-14 and 0-28, whereas HES showed a similar effect only during days 8-14 compared to the control diet (p < 0.05). Additionally, feed additives decreased packed cell volume, left and right ventricle volumes and systolic blood pressure (p < 0.05). Moreover, chickens fed the control and l-arginine diets exhibited higher levels of angiotensin converting enzyme (ACE) mRNA in lung tissue compared to those fed HES, HEM and captopril (p < 0.05). Meanwhile, supplementation with HEM and l-arginine increased the expression of inducible nitric oxide synthase (iNOS) mRNA in lung tissue compared to other treatments (p < 0.05). Regarding Cu/Zn-superoxide dismutase (Cu/Zn-SOD) expression, feed additives increased mRNA level in lung tissue, except for captopril (p < 0.05). CONCLUSIONS: This study demonstrates that the plant extracts may reduce the incidence of ascites syndrome not only through their antioxidant properties but also by modulating the expression of ACE, iNOS and Cu/Zn-SOD genes.


Asunto(s)
Alimentación Animal , Arginina , Ascitis , Captopril , Pollos , Dieta , Suplementos Dietéticos , Enfermedades de las Aves de Corral , Vitamina E , Animales , Captopril/administración & dosificación , Arginina/administración & dosificación , Arginina/metabolismo , Ascitis/veterinaria , Ascitis/genética , Ascitis/metabolismo , Dieta/veterinaria , Masculino , Alimentación Animal/análisis , Enfermedades de las Aves de Corral/tratamiento farmacológico , Suplementos Dietéticos/análisis , Vitamina E/administración & dosificación , Frío , Distribución Aleatoria , Expresión Génica/efectos de los fármacos
8.
Rev. esp. enferm. dig ; 99(10): 599-603, oct. 2007.
Artículo en Es | IBECS (España) | ID: ibc-63284

RESUMEN

Durante la última década hemos presenciado un aumento de lacantidad de datos relativos a la presencia de translocación bacterianaen los modelos experimentales de cirrosis. Sin embargo, losestudios clínicos se han visto limitados por la falta de métodos noinvasivos para estudiar dicho fenómeno. En los últimos años, lasinvestigaciones realizadas en nuestro laboratorio se han centradoen la detección del ADN bacteriano en el suero y el líquido ascíticode los pacientes con cirrosis y ascitis estéril, y en las implicacionesclínicas que ello conlleva. Al principio, gracias a un métodobasado en la reacción en cadena de la polimerasa (PCR) y el secuenciamientoautomatizado de nucleótidos, pudimos detectar eidentificar la presencia de fragmentos de ADN bacteriano en dichospacientes con ascitis no neutrocítica y con cultivo negativo.Desde entonces hemos acumulado una serie de datos que indicanque la presencia de ADN bacteriano podría desempeñar un papelimportante no sólo como marcador de translocación bacteriana,sino también como factor pronóstico a corto plazo. Expondremosaquí el pasado, el presente y el futuro de esta línea de investigación


During the last decade, we have witnessed an increase in theamount of data related with the presence of bacterial translocationin experimental models of cirrhosis. However, clinical studies havebeen limited by the lack of non-invasive methods to study this phenomenon.Over the past years, the research developed in our laboratoryhas been focused on the detection of bacterial DNA inserum and ascitic fluid of patients with cirrhosis and sterile ascites,the clinical and immunological implications of such finding. Initially,by means of a polymerase chain reaction (PCR)-based methodand automated nucleotide sequencing, we were able to detect andidentify the presence of fragments of bacterial DNA in the mentionedpatients with culture-negative, non-neutrocytic ascites.Since then, we have accumulated a core of data suggesting thatthe presence of bacterial DNA may have an important role notonly as a marker of bacterial translocation, but also as a shorttermprognostic factor. Here, we discuss the past, present and futureof this line of investigation


Asunto(s)
Humanos , Animales , ADN Bacteriano/análisis , Traslocación Bacteriana/genética , Cirrosis Hepática/genética , Ascitis/genética , Marcadores Genéticos , Líquido Ascítico/genética , Reacción en Cadena de la Polimerasa , Proteínas Portadoras/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA